Market Tracker

07/29 5:16pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.17
Delayed Data
As of Jul 29
 +0.13 / +1.62%
Today’s Change
4.15
Today|||52-Week Range
10.74
-4.44%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close8.04
Today’s open8.11
Day’s range8.00 - 8.30
Volume17,027
Average volume (3 months)127,560
Market cap$105.6M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-8.06%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.74

Competitors

 Today’s
change
Today’s
% change
TTNPTitan Pharmaceutical...-0.08-1.59%
AKAOAchaogen Inc+0.01+0.26%
XENEXenon Pharmaceutical...+0.18+2.41%
DPRXDipexium Pharmaceuti...-0.04-0.38%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateNovember 23, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$0.00
Annual profit (last year)-$7.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts